Axogen FY 2021: revenue $127.4M, up 13%; diluted EPS −$0.65

Key figures from this report

These are the numbers Axogen reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$127.4M+13% from $112.3M in FY 202010-K income statement, on EDGAR
2. Net income−$27.0MAgainst −$23.8M in FY 202010-K income statement, on EDGAR
3. Diluted EPS−$0.65Against −$0.60 in FY 202010-K income statement, on EDGAR
4. Cash and cash equivalents$32.8M−33% from $48.8M in FY 2020Cash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$13.4MAgainst −$9.6M in FY 202010-K cash flow statement, on EDGAR

Every year in the financial tables